With the analysis among 3,057 patents, we discovered top 442 key players by total patent application. Immatics Biotechnologies GmbH, F. Hoffmann-La Roche Ltd., Ganymed Pharmaceuticals AG are dominant in this area. They take 12.01% of the total patent filing.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 186
F. Hoffmann-La Roche Ltd.
Ganymed Pharmaceuticals AG
Rheinland-Pfalz, Germany
Patent: 55
Centre of Molecular Immunology
German Cancer Research Center (Deutsches Krebsforschungszentrum, DKFZ)
California, United States
Patent: 42
OncoTherapy Science, Inc.
Kanagawa-ken, Japan
Patent: 32
Human Genome Sciences, Inc.
Hessen, Germany
Patent: 31
Boehringer Ingelheim International GmbH
Rheinland-Pfalz, Germany
Patent: 28
With the analysis among 48 patents, we discovered top 14 start-ups by total patent application. Institut National de la Santé et de la Recherche Médicale, Aleta Biotherapeutics, Inc., OncoQuest, Inc. are active in this area.
Institut National de la Santé et de la Recherche Médicale
Aleta Biotherapeutics, Inc.
Massachusetts, United States
Patent: 5
Cytoimmune Therapeutics, Inc.
California, United States
Patent: 2
Calidi Biotherapeutics, Inc.
California, United States
Patent: 2
New York, United States
Patent: 1
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
Primevax Immuno-Oncology, Inc.
California, United States
Patent: 1
Basel-Stadt, Switzerland
Patent: 1
With the analysis among related 198 patents applied in the last 5 years. We discover 132 most active companies in this area. The fast-growing Immatics Biotechnologies GmbH, Synlogic Operating Co., Inc., Inovio Pharmaceuticals, Inc. take 20.71% of patent filing during this period.
Immatics Biotechnologies GmbH
Baden-Württemberg, Germany
Patent: 31
Synlogic Operating Co., Inc.
Massachusetts, United States
Patent: 6
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 4
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 3
New Jersey, United States
Patent: 3
Hangzhou Converd Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Massachusetts, United States
Patent: 2
TRON - Translationale Onkologie an der Universitätsmedizin der
Rheinland-Pfalz, Germany
Patent: 2
Oregon, United States
Patent: 2
Yunnan Sheng, China
Patent: 2
With the analysis among related 198 patents in last 5 years, we discover 74 new entrants. Inovio Pharmaceuticals, Inc., Iovance Biotherapeutics, Inc., Hangzhou Converd Co., Ltd. are the most active new entrants in this area.
Inovio Pharmaceuticals, Inc.
Pennsylvania, United States
Patent: 4
Iovance Biotherapeutics, Inc.
New York, United States
Patent: 3
Hangzhou Converd Co., Ltd.
Zhejiang Sheng, China
Patent: 3
Massachusetts, United States
Patent: 2
OncoPlex Diagnostics, Inc.
Oregon, United States
Patent: 2
Providence Health & Services - Oregon
Oregon, United States
Patent: 2
Yunnan Sheng, China
Patent: 2
Kansas, United States
Patent: 2
DRAGONFLY Therapeutics, Inc.
Massachusetts, United States
Patent: 1
With the analysis among 1,305 patents, we discovered top 221 universities and scientific research institutions by total patent application. The Johns Hopkins University, The Scripps Research Institute, New York University are dominant in this area. They take 11.19% of the total patent filing.
The Johns Hopkins University
The Scripps Research Institute
California, United States
Patent: 38
New York, United States
Patent: 23
Georgetown University School of Medicine
District of Columbia, United States
Patent: 23
Thomas Jefferson University
Pennsylvania, United States
Patent: 20
The Johannes Gutenberg University of Mainz
Rheinland-Pfalz, Germany
Patent: 17
Georgia, United States
Patent: 16
New York, United States
Patent: 15
Tennessee, United States
Patent: 14
Ruprecht-Karls-Universität Heidelberg
Baden-Württemberg, Germany
Patent: 14